Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.

Intracranial haemorrhage (ICH) is a complication described in anticoagulant (AC) therapy, as well as in platelet antiaggregant (PAA) therapy. The ‘Hospital Italiano’ of Cordoba province holds a large number of elderly adults who are frequently treated with the mentioned therapies for diverse conditi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoulund, GA, Contrera, P, Vignoni, G, Castrillón , ME
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2019
Materias:
computed tomography
intracranial haemorrhage
anticoagulants
platelet antiaggregant
tomografía computarizada
hemorragia intracraneana
anticoagulantes
antiagregantes de plaquetas.
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/25892
Aporte de:
Revista de la Facultad de Ciencias Médicas de Córdoba de Universidad Nacional de Córdoba
id I10-R327-article-25892
record_format ojs
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-327
container_title_str Revista de la Facultad de Ciencias Médicas de Córdoba
language Español
format Artículo revista
topic computed tomography
intracranial haemorrhage
anticoagulants
platelet antiaggregant
tomografía computarizada
hemorragia intracraneana
anticoagulantes
antiagregantes de plaquetas.
spellingShingle computed tomography
intracranial haemorrhage
anticoagulants
platelet antiaggregant
tomografía computarizada
hemorragia intracraneana
anticoagulantes
antiagregantes de plaquetas.
Schoulund, GA
Contrera, P
Vignoni, G
Castrillón , ME
Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
topic_facet computed tomography
intracranial haemorrhage
anticoagulants
platelet antiaggregant
tomografía computarizada
hemorragia intracraneana
anticoagulantes
antiagregantes de plaquetas.
author Schoulund, GA
Contrera, P
Vignoni, G
Castrillón , ME
author_facet Schoulund, GA
Contrera, P
Vignoni, G
Castrillón , ME
author_sort Schoulund, GA
title Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
title_short Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
title_full Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
title_fullStr Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
title_full_unstemmed Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
title_sort incidence of intracranial haemorrhage in computed tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy.
description Intracranial haemorrhage (ICH) is a complication described in anticoagulant (AC) therapy, as well as in platelet antiaggregant (PAA) therapy. The ‘Hospital Italiano’ of Cordoba province holds a large number of elderly adults who are frequently treated with the mentioned therapies for diverse conditions. computed tomography (CT) is used to detect intracranial haemorrhage lesions,. The objective was to determine the incidence of intracranial haemorrhage (ICH) in tomographic studies of patients undergoing an anticoagulant or platelet antiaggregant therapy, treated in Hospital Italiano. To describe the possible causes and location of ICH. To identify the prevalence of associated risk factors such as hypertension (HT), diabetes mellitus, current smoking and dyslipidaemia Retrospective and descriptive review of 186 ICH cases diagnosed usin brain CT scan without contrast from patients a the Image Diagnosis Service of the Hospital Italiano of Cordoba from 1/01/2018 to 31/5/2019. Analysis of the Electronic medical history to evaluate the background and the risk factors. ICH under AC or PAA therapy 17.74% (n=33). PAA: 75.75% (n=25). AC: 24.24% (n=8).  Traumatic brain injury (TBI): 21% (n=7). Male/Female: 17/16. Age range: 58-89 years (mean 76,5 years). Intraparenchymal haemorrhage (IPH): 72.72% (n=24), Subdural hematoma (SDH): 27.27% (n=9), Epidural  hematoma (EDH): 0, Subarachnoid haemorrhage (SAH): 21.21% (n=7), Intraventricular haemorrhage (IVH): 24.24 % (n=8).  Risk factors: HT: 97.87 % (n=29). Diabetes: 33.33% (n=11). Current smoking: 9.09% (n=3). Dyslipidaemia: 36.36% (n=12).   A 17% of the patients with ICH were undergoing an anticoagulant or platelet antiaggregant therapy, 21% of them with previous TBI. The Intraparenchymal haemorrhage was the most frequent location. The most prevalent risk factor was hypertension (HT)
publisher Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2019
url https://revistas.unc.edu.ar/index.php/med/article/view/25892
work_keys_str_mv AT schoulundga incidenceofintracranialhaemorrhageincomputedtomographyinpatientsundergoingananticoagulantorplateletantiaggreganttherapy
AT contrerap incidenceofintracranialhaemorrhageincomputedtomographyinpatientsundergoingananticoagulantorplateletantiaggreganttherapy
AT vignonig incidenceofintracranialhaemorrhageincomputedtomographyinpatientsundergoingananticoagulantorplateletantiaggreganttherapy
AT castrillonme incidenceofintracranialhaemorrhageincomputedtomographyinpatientsundergoingananticoagulantorplateletantiaggreganttherapy
AT schoulundga incidenciadehemorragiaintracraneanaentomografiacomputadadepacientescontratamientodeantiagregantesoanticoagulantes
AT contrerap incidenciadehemorragiaintracraneanaentomografiacomputadadepacientescontratamientodeantiagregantesoanticoagulantes
AT vignonig incidenciadehemorragiaintracraneanaentomografiacomputadadepacientescontratamientodeantiagregantesoanticoagulantes
AT castrillonme incidenciadehemorragiaintracraneanaentomografiacomputadadepacientescontratamientodeantiagregantesoanticoagulantes
first_indexed 2024-09-03T21:01:16Z
last_indexed 2024-09-03T21:01:16Z
_version_ 1809210174610604032
spelling I10-R327-article-258922024-08-27T18:26:35Z Incidence of Intracranial haemorrhage in Computed Tomography in patients undergoing an anticoagulant or platelet antiaggregant therapy. Incidencia de hemorragia intracraneana en Tomografía Computada de pacientes con tratamiento de antiagregantes o anticoagulantes. Schoulund, GA Contrera, P Vignoni, G Castrillón , ME computed tomography intracranial haemorrhage anticoagulants platelet antiaggregant tomografía computarizada hemorragia intracraneana anticoagulantes antiagregantes de plaquetas. Intracranial haemorrhage (ICH) is a complication described in anticoagulant (AC) therapy, as well as in platelet antiaggregant (PAA) therapy. The ‘Hospital Italiano’ of Cordoba province holds a large number of elderly adults who are frequently treated with the mentioned therapies for diverse conditions. computed tomography (CT) is used to detect intracranial haemorrhage lesions,. The objective was to determine the incidence of intracranial haemorrhage (ICH) in tomographic studies of patients undergoing an anticoagulant or platelet antiaggregant therapy, treated in Hospital Italiano. To describe the possible causes and location of ICH. To identify the prevalence of associated risk factors such as hypertension (HT), diabetes mellitus, current smoking and dyslipidaemia Retrospective and descriptive review of 186 ICH cases diagnosed usin brain CT scan without contrast from patients a the Image Diagnosis Service of the Hospital Italiano of Cordoba from 1/01/2018 to 31/5/2019. Analysis of the Electronic medical history to evaluate the background and the risk factors. ICH under AC or PAA therapy 17.74% (n=33). PAA: 75.75% (n=25). AC: 24.24% (n=8).  Traumatic brain injury (TBI): 21% (n=7). Male/Female: 17/16. Age range: 58-89 years (mean 76,5 years). Intraparenchymal haemorrhage (IPH): 72.72% (n=24), Subdural hematoma (SDH): 27.27% (n=9), Epidural  hematoma (EDH): 0, Subarachnoid haemorrhage (SAH): 21.21% (n=7), Intraventricular haemorrhage (IVH): 24.24 % (n=8).  Risk factors: HT: 97.87 % (n=29). Diabetes: 33.33% (n=11). Current smoking: 9.09% (n=3). Dyslipidaemia: 36.36% (n=12).   A 17% of the patients with ICH were undergoing an anticoagulant or platelet antiaggregant therapy, 21% of them with previous TBI. The Intraparenchymal haemorrhage was the most frequent location. The most prevalent risk factor was hypertension (HT) La hemorragia intracraneana (HIC) es una complicación descripta en la terapia con anticoagulantes (AC), así como con antiagregantes (AA). El Hospital Italiano de la ciudad de Córdoba posee un elevado número de pacientes adultos mayores, los cuales con frecuencia reciben estos tratamientos para variadas condiciones. Para la detección de lesiones hemorrágicas intracraneanas se utiliza tomografía computada (TC). El objetivo del trabajo fue determinar la incidencia en estudios tomográficos de HIC en pacientes bajo tratamiento con anticoagulantes o antiagregantes plaquetarios tratados en el Hospital Italiano. Describir causa y localización de la HIC. Identificar la prevalencia de factores de riesgo asociados como HTA, Diabetes mellitus, tabaquismo y dislipemia. Revisión retrospectiva y descriptiva de casos diagnosticados de HIC mediante TC de cerebro sin contraste en el Servicio de Diagnóstico por Imágenes del Hospital Italiano de Córdoba. Periodo 1/01/2018 a 31/05/2019, con análisis de la Historia Clínica Electrónica para valorar antecedentes de factores de riesgo. Se analizaron un total de 186 TC de pacientes con diagnóstico de HIC. HIC que estaban bajo tratamiento con AC o AA: 17.74% (n=33). AA: 75.75% (n=25). AC: 24.24% (n=8).  Traumatismo Craneoencefálico (TCE): 21% (n=7). Masculino/Femenino: 17/16. Rango edad: 58-89 años (media 76,5 años). Hemorragia intraparenquimatosa (HIP): 72.72% (n=24), Hemorragia subdural (HSD): 27.27% (n=9), Hemorragia epidural (HED): 0, Hemorragia subaracnoidea (HSA): 21.21% (n=7), Hemorragia intraventricular (HIV): 24.24 % (n=8).  Factores de riesgo: HTA: 97.87 % (n=29). Diabetes: 33.33% (n=11). Tabaquismo: 9.09% (n=3). Dislipemia: 36.36% (n=12).   Un 17% de los pacientes con HIC estaban con tratamiento con antiagregantes o anticoagulantes, 21% de ellos con TCE previo. La Hemorragia intraparenquimatosa fue la localización más frecuente. El factor de riesgo con mayor relación es HTA. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2019-10-22 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://revistas.unc.edu.ar/index.php/med/article/view/25892 Revista de la Facultad de Ciencias Médicas de Córdoba.; 2019: Suplemento JIC XX Revista de la Facultad de Ciencias Médicas de Córdoba; 2019: Suplemento JIC XX Revista da Faculdade de Ciências Médicas de Córdoba; 2019: Suplemento JIC XX 1853-0605 0014-6722 10.31053/1853.0605.v76.nSuplemento spa https://revistas.unc.edu.ar/index.php/med/article/view/25892/27712 Derechos de autor 2019 Universidad Nacional de Córdoba https://creativecommons.org/licenses/by-nc/4.0

Ejemplares similares